Stanford V

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

WikiDoc Resources for Stanford V

Articles

Most recent articles on Stanford V

Most cited articles on Stanford V

Review articles on Stanford V

Articles on Stanford V in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Stanford V

Images of Stanford V

Photos of Stanford V

Podcasts & MP3s on Stanford V

Videos on Stanford V

Evidence Based Medicine

Cochrane Collaboration on Stanford V

Bandolier on Stanford V

TRIP on Stanford V

Clinical Trials

Ongoing Trials on Stanford V at Clinical Trials.gov

Trial results on Stanford V

Clinical Trials on Stanford V at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Stanford V

NICE Guidance on Stanford V

NHS PRODIGY Guidance

FDA on Stanford V

CDC on Stanford V

Books

Books on Stanford V

News

Stanford V in the news

Be alerted to news on Stanford V

News trends on Stanford V

Commentary

Blogs on Stanford V

Definitions

Definitions of Stanford V

Patient Resources / Community

Patient resources on Stanford V

Discussion groups on Stanford V

Patient Handouts on Stanford V

Directions to Hospitals Treating Stanford V

Risk calculators and risk factors for Stanford V

Healthcare Provider Resources

Symptoms of Stanford V

Causes & Risk Factors for Stanford V

Diagnostic studies for Stanford V

Treatment of Stanford V

Continuing Medical Education (CME)

CME Programs on Stanford V

International

Stanford V en Espanol

Stanford V en Francais

Business

Stanford V in the Marketplace

Patents on Stanford V

Experimental / Informatics

List of terms related to Stanford V


Overview

Stanford V is a chemotherapy regimen designed for Hodgkin's lymphoma that consists of the following:

It is a newer method than MOPP or ABVD, the two previous most common treatments for Hodgkin's lymphoma.

The chemotherapy part of Stanford V treatment can last anywhere from 8 to 12 weeks, depending on the staging of the disease. In many cases, this is followed by radiation therapy for anywhere from 2 to 6 weeks to the affected areas of the body.

It is believed that Stanford V is at least as effective as other methods of treatment. Stanford V is a more rigorously administered form of chemotherapy, with treatments roughly twice as fast as those of other Hodgkin's lymphoma treatments; however, this is tempered by the need for radiation therapy in most cases which is not typically required under ABVD.

External links


Template:Chemotherapeutic Agents Template:WH Template:WS